These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9858650)

  • 1. Setting up of an original computer-assisted methodology to characterize in vitro drug-induced anti-angiogenic effects.
    Farinelle S; Dehauwer C; Darro F; Decaestecker C; Fontaine J; Pasteels JL; Van Ham P; Atassi G; Kiss R
    Int J Mol Med; 1998 Nov; 2(5):545-53. PubMed ID: 9858650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
    Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
    J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNP-470: an angiogenesis inhibitor in clinical development for cancer.
    Kruger EA; Figg WD
    Expert Opin Investig Drugs; 2000 Jun; 9(6):1383-96. PubMed ID: 11060750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1.
    Zhang Y; Griffith EC; Sage J; Jacks T; Liu JO
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6427-32. PubMed ID: 10841547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the angiogenesis inhibitor TNP-470 on murine lymphoma/leukemia cells in vivo and in vitro.
    Norén-Nyström U; Eriksson M; Eriksson B; Roos G; Bergh A; Holmberg D
    Exp Hematol; 2003 Feb; 31(2):143-9. PubMed ID: 12591279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470.
    Miura S; Emoto M; Matsuo Y; Kawarabayashi T; Saku K
    Cancer Lett; 2004 Jan; 203(1):45-50. PubMed ID: 14670616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
    Chesler L; Goldenberg DD; Seales IT; Satchi-Fainaro R; Grimmer M; Collins R; Struett C; Nguyen KN; Kim G; Tihan T; Bao Y; Brekken RA; Bergers G; Folkman J; Weiss WA
    Cancer Res; 2007 Oct; 67(19):9435-42. PubMed ID: 17909053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.
    Beecken WD; Fernandez A; Joussen AM; Achilles EG; Flynn E; Lo KM; Gillies SD; Javaherian K; Folkman J; Shing Y
    J Natl Cancer Inst; 2001 Mar; 93(5):382-7. PubMed ID: 11238700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of TNP-470 on proliferation and apoptosis in human colon cancer xenografts in nude mice.
    Huang ZH; Fan YF; Xia H; Feng HM; Tang FX
    World J Gastroenterol; 2003 Feb; 9(2):281-3. PubMed ID: 12532448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).
    Kusaka M; Sudo K; Matsutani E; Kozai Y; Marui S; Fujita T; Ingber D; Folkman J
    Br J Cancer; 1994 Feb; 69(2):212-6. PubMed ID: 8297716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
    Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
    J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice.
    Zhou YF; Mori T; Kudo H; Asakai R; Sassa S; Sakamoto S
    Fertil Steril; 2003 Sep; 80 Suppl 2():788-94. PubMed ID: 14505755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malignant neuroectodermic tumor.
    Morales C; Zurita M; Vaquero J
    J Neurooncol; 2002 Jun; 58(2):131-6. PubMed ID: 12164684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiangiogenic treatment of cancer].
    Mauriz JL; Linares P; González P; Culebras JM
    Cir Esp; 2005 Jul; 78(1):3-11. PubMed ID: 16420784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interaction.
    Mekapati SB; Hansch C
    Bioorg Med Chem; 2001 Dec; 9(12):3225-30. PubMed ID: 11711298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo.
    Fan YF; Huang ZH
    World J Gastroenterol; 2002 Oct; 8(5):853-6. PubMed ID: 12378629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically.
    Minischetti M; Vacca A; Ribatti D; Iurlaro M; Ria R; Pellegrino A; Gasparini G; Dammacco AF
    Br J Haematol; 2000 Jun; 109(4):829-37. PubMed ID: 10929037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of the anti-angiogenesis drug TNP-470.
    Gervaz P; Fontolliet C
    Int J Exp Pathol; 1998 Dec; 79(6):359-62. PubMed ID: 10319017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of novel fumagillin analogues as angiogenesis inhibitors.
    Pyun HJ; Fardis M; Tario J; Yang CY; Ruckman J; Henninger D; Jin H; Kim CU
    Bioorg Med Chem Lett; 2004 Jan; 14(1):91-4. PubMed ID: 14684305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents.
    Teicher BA; Holden SA; Ara G; Sotomayor EA; Huang ZD; Chen YN; Brem H
    Int J Cancer; 1994 Jun; 57(6):920-5. PubMed ID: 7515861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.